IRulya Therapeutics, Inc. (IRLA)
31.00
+1.69
(+5.77%)
USD |
NASDAQ |
Nov 06, 16:00
30.85
-0.15
(-0.48%)
After-Hours: 20:00
IRulya Therapeutics Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.293M |
| December 31, 2025 | 18.36M |
| September 30, 2025 | 0.359M |
| June 30, 2025 | 17.38M |
| March 31, 2025 | 15.65M |
| December 31, 2024 | 14.72M |
| September 30, 2024 | 15.35M |
| June 30, 2024 | 14.29M |
| March 31, 2024 | 14.00M |
| December 31, 2023 | 13.75M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.076M |
| September 30, 2022 | 0.128M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.207M |
| March 31, 2022 | 0.04M |
| December 31, 2021 | 0.42M |
| September 30, 2021 | 0.61M |
| June 30, 2021 | 0.773M |
| March 31, 2021 | 0.171M |
| December 31, 2020 | 0.208M |
| September 30, 2020 | 0.244M |
| June 30, 2020 | 0.05M |
| March 31, 2020 | 0.057M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.475M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 0.984M |
| PepGen Inc. | 12.86M |
| Q32 Bio, Inc. | 4.364M |
| Bridgebio Oncology Therapeutics, Inc. | 1.96M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |